Comparison
Armodafinil vs Lion's Mane
Side-by-side of Armodafinil and Lion's Mane. Every row below is pulled from the compound schema and will update as our data grows. For deeper reads, follow through to each compound page.
Armodafinil
Armodafinil is the R-enantiomer sold as Nuvigil. Half-life 10-15 h, 150 mg standard dose, narcolepsy and shift-work approvals, Schedule IV.
Lion's Mane
Lion's mane mushroom (Hericium erinaceus) supplement profile: hericenones and erinacines stimulate NGF in vitro. Human cognition trials are small.
Effects at a glance
Armodafinil
- •FDA approved in 2007 for narcolepsy, shift-work sleep disorder, and OSA residual sleepiness
- •R-enantiomer of modafinil; 150 mg armodafinil is roughly equivalent to 200 mg modafinil
- •Schedule IV controlled in the US; prescription-only globally
- •Longer terminal half-life of about 15 hours produces extended late-day wakefulness coverage
- •Same CYP3A4 induction as modafinil; reduces hormonal contraceptive efficacy
- •Side-effect profile and dermatologic risk warnings mirror modafinil
Lion's Mane
- •Edible medicinal mushroom containing NGF-stimulating hericenones and erinacines
- •Mori 2009 trial (n=30) in mild cognitive impairment showed cognitive improvement at 3 g/day for 16 weeks, reversing 4 weeks after discontinuation
- •Saitsu 2019 (n=31) in older adults reported MoCA improvements at 3.2 g/day over 12 weeks
- •Multiple small mood trials suggest reduced anxiety and depression scores at 1 to 4 g/day extract
- •Mechanistic case rests on NGF stimulation and remyelination support; in vivo human NGF measurement is absent
- •Product quality varies substantially; mycelium-on-grain products can be over 50% grain by weight
Side-by-side
| Attribute | Armodafinil | Lion's Mane |
|---|---|---|
| Category | pharmaceutical | natural |
| Also known as | Nuvigil, R-modafinil, (R)-(-)-modafinil | Hericium erinaceus, Yamabushitake, Bearded Tooth, Hou Tou Gu |
| Half-life (hr) ↗ | 15 | 6 |
| Typical dose (mg) ↗ | 150 | 1000 |
| Dosing frequency | daily, morning | 1 to 2 times daily |
| Routes | oral | oral |
| Onset (hr) | 1 | 168 |
| Peak (hr) | 3 | 1344 |
| Molecular weight | 273.35 | - |
| Molecular formula | C15H15NO2S | mixed extract |
| Mechanism | Weak dopamine reuptake inhibition plus downstream activation of histaminergic, noradrenergic, and orexinergic wake systems; R-enantiomer of modafinil with longer half-life. | Hericenones and erinacines stimulate NGF mRNA expression and NGF protein release in cultured neurons; secondary anti-inflammatory and remyelination-supportive activity in preclinical models. |
| Legal status | Schedule IV (US); prescription-only globally; not a supplement | Dietary supplement and food worldwide; unscheduled and unrestricted |
| WADA status | banned | allowed |
| DEA / Rx | Schedule IV | OTC supplement and food |
| Pregnancy | Not recommended | Insufficient data for routine supplementation; consumed historically as food without documented harm |
| CAS | 112111-43-0 | |
| PubChem CID | 9148206 | |
| Wikidata | Q4791953 | Q146050 |
Safety profile
Armodafinil
Common side effects
- headache
- nausea
- dizziness
- anxiety
- insomnia (with later-day dosing)
- dry mouth
- mild blood pressure elevation
Contraindications
- recent myocardial infarction
- unstable angina
- left ventricular hypertrophy
- significant arrhythmia
- history of Stevens-Johnson syndrome
- psychotic disorders
- pregnancy
- concurrent MAOI use
Interactions
- hormonal contraceptives: CYP3A4 induction reduces contraceptive efficacy; use barrier method(major)
- cyclosporine: reduced cyclosporine levels via CYP3A4 induction(major)
- warfarin: CYP2C9 inhibition raises INR(moderate)
- phenytoin: CYP2C19 inhibition raises phenytoin levels(moderate)
- MAOIs: potential hypertensive reaction(major)
- classical stimulants: additive cardiovascular and sleep-disruption effects(moderate)
Lion's Mane
Common side effects
- mild GI upset
- occasional skin rash
- contact dermatitis (rare)
Contraindications
- mushroom allergy
Interactions
- anticoagulants: theoretical antiplatelet effect, no documented clinical events(minor)
Which Should You Take?
Lion's Mane comes out ahead for most readers on the criteria we weight: 3 catalogued goals, OTC dietary supplement, oral dosing, with a Tier-B outcome catalogued. Armodafinil is the right call when one of the conditionals below applies.
- → If your priority is wakefulness, pick Armodafinil.
- → If your priority is fatigue resistance, pick Armodafinil.
- → If your priority is nerve health, pick Lion's Mane.
- → If your priority is mood, pick Lion's Mane.
Edge case: If you want to avoid controlled substance, Lion's Mane is the more accessible choice.
Default choice: Lion's Mane. Lower friction to source, and broader goal coverage. Reach for Armodafinil only if your priority sits squarely in the goals it owns above.
This verdict is generated from each compound's schema (goals, legal status, evidence outcomes, dosing route). It updates automatically as our compound data evolves; the deeper read sits on each individual compound page.
Common questions
What is the difference between Armodafinil and Lion's Mane?
Armodafinil and Lion's Mane differ in category (pharmaceutical vs natural), mechanism, and typical dosing. See the side-by-side table for full details.
Which has a longer half-life, Armodafinil or Lion's Mane?
Armodafinil half-life is 15 hours; Lion's Mane half-life is 6 hours.
Can you stack Armodafinil with Lion's Mane?
Stack compatibility depends on mechanism overlap, legal status, and individual response. Check each compound page for specific interactions and contraindications before combining.
Go deeper